Navigation Links
Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation
Date:5/12/2009

Leader in Web-based admissions software for long-term care will present technology and admissions educational sessions for ACHCA members

Atlanta, GA (PRWEB) May 12, 2009 --Patient Placement Systems, the leading provider of automated Web-based admissions for long-term care providers, announced today that it will exhibit and present two sessions at the American College of Health Care Administrators (ACHCA) 2009 Annual Convocation and Exposition. The convocation takes place May 15-19 at the Rhode Island Convention Center in Providence, R.I.

Doug Walker, VP and General Manager of Patient Placement Systems, will present to ACHCA members on the topics of "Boosting Census and Revenue with New Admissions Technologies" and "4 Steps to Help Embrace New Technologies in Long-Term Care." Patient Placement Systems based much of the presentation content a series of long-term care surveys conducted over the past 18 months.

"ACHCA promotes excellence and leadership in the long-term care industry, and we're honored to speak and participate at this year's ACHCA convocation," said Doug Walker, VP and General Manager for Patient Placement Systems. "We're excited to share ideas, recommendations, and eye-opening results of our industry research with ACHCA members, and help them understand and embrace technology solutions that improve care and productivity."

Walker noted some specific research results that highlight the challenges of long-term care admissions. For example, the average skilled nursing facility receives 1,110 patient referrals annually and manually manages 27,000 pages of documentation.
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alliance for Patient Access Wants Health Care Code of Conduct
2. State-of-the-Art Technology and Hotel-Like Environment Get CareOnes Rehab Patients Home Quicker
3. Patients Call for Continued FDA Preemption Authority
4. More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro
5. Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance
6. Videoconferencing can increase patient access to stroke specialists
7. Avalere Shows Home Health Interventions Associated with Lower Medicare Spending and Re-Hospitalizations for Patients With Chronic Illness
8. Surgery improves survival for prostate cancer patients younger than 50
9. Over 3,000 Skin Cancer Patients Treated with the TOPEX System.............
10. Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
11. Patient Command Tells Sec. Sebelius That Existing Technology Can Make Electronic Health Records Interoperable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... (PRWEB) September 02, 2014 “Australia Hernia ... on the Australia Hernia Repair market. The report provides ... and average prices (in US dollars) within market segments ... and Synthetic 3D Meshes) ,     Composite Meshes and ... a surgical operation for the correction of a hernia ...
(Date:9/1/2014)... Sept. 1, 2014 (HealthDay News) -- Having regular family ... health effects of "cyberbullying," a new study suggests. ... thoughts, according to experts. "One in five adolescents ... for Health and Social Policy at McGill University in ... adolescents use social media, and online harassment and abuse ...
(Date:9/1/2014)... health and substance use problems in adolescents but ... consequences of cyberbullying and also be beneficial for ... Ph.D., of McGill University, Montreal, Canada, and colleagues. ... experienced recent online bullying and cyberbullying, like traditional ... problems in teens as well as the misuse ...
(Date:9/1/2014)... HealthDay Reporter SATURDAY, Aug. 30, ... experimental drug was more effective than standard treatment at ... According to the study authors, the trial was stopped ... drug, dubbed LCZ696. In the trial, 26.5 ... either died or were hospitalized due to heart failure, ...
(Date:9/1/2014)... News) -- Watching action shows on TV may be bad ... much more snack food while watching action films and programs ... "We find that if you,re watching an action movie ... author Aner Tal, of the Cornell Food and Brand Lab, ... more distracting the program is, the more you will eat." ...
Breaking Medicine News(10 mins):Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 2Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 3Health News:Action-Packed TV a Threat to Your Waistline? 2
... halt premature labor may be associated with brain damage and intestinal ... on the issue published today in American Journal of Obstetrics and ... are faced with the possibility of delivering a baby who is ... will be given both a tocolytic agent, or drug used to ...
... (positron emission tomography) that measures uptake of sugar in ... type of dementia often mistaken for Alzheimers disease, a ... has found. , The scan, FDG-PET, helped six doctors ... dementia (FTD) and Alzheimers in almost 90 percent of ...
... year of advancing cancer research, the American Association for ... Europe, and Asia. The AACR has teamed with ... Science, Technology and Research (A*STAR) to hold the first ... Singapore: the AACR Centennial Conference on Translational Cancer Medicine: ...
... 1, 2007) Diabetes is a very common illness that ... it is estimated an additional 54 million Americans have pre-diabetes, ... are higher than normal but not high enough for a ... determine whether glucose and insulin levels are associated with a ...
... ADA President Mark J. Feldman:, "The American Dental ... for introducing legislation that will help bring more,dentists into ... too many people lack sufficient access to the basic ... Native American Full Access to Dental Care Act (H.R. ...
... Wash., Nov. 1 BLU-MED Response Systems ... and distribution,facility near Boise, Idaho. BLU-MED produces ... use as mobile field hospitals,emergency medical stations, ... facilities are used by Federal, state and ...
Cached Medicine News:Health News:Common drug for stopping preterm labor may be harmful for babies 2Health News:PET scan distinguishes Alzheimer's from other dementia 2Health News:PET scan distinguishes Alzheimer's from other dementia 3Health News:Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference 2Health News:Increased glucose level is a strong risk factor for colorectal cancer 2Health News:Increased glucose level is a strong risk factor for colorectal cancer 3Health News:Statement by ADA President Mark J. Feldman on the Native American Full Access to Dental Care Act 2Health News:BLU-MED Response Systems Announces New Production Facility in Idaho 2
(Date:9/1/2014)... 2014 Reportbuyer.com has added a new ... Lasers and Energy Devices Market Outlook to 2020, ... Brazil Aesthetic Lasers and Energy Devices Market ... GlobalData,s new report, "Brazil Aesthetic Lasers and ... market data on the Brazil Aesthetic Lasers and ...
(Date:9/1/2014)... NEW YORK , Sept. 1, 2014 /PRNewswire/ ... new market research report is available in its ... Edition), 2014 - 2024 ... conjugates (ADCs) are a new class of therapeutic ... small pharmaceutical companies. Generally addressed as the marriage ...
(Date:9/1/2014)... 1, 2014 Reportlinker.com announces that a ... catalogue:  Drug Discovery Technologies - A Global ... The development of new drugs ... extensive expenditure, in addition to consuming a lot ... new drug involves the utilizing high-throughput screening of ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 2Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 3Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 4Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 5Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 6Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 7Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 8Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 10Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 11Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 12Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 13Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 14Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 15Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 16Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 17Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 18Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11
... Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharma (TASE:CFBI), a ... Exchange, proceeds with the development of its,third drug ... is currently,in clinical trials and CF102, which is ... the EUALR annual congress of,rheumatology in-vitro and in ...
... of SLE,disease at 52 Weeks and demonstrated ... ROCKVILLE, Md., June 14, 2007 /PRNewswire-FirstCall/ -- ... of Phase 2,trial data demonstrating that LymphoStat-B(R) ... was well tolerated and improved quality of ...
Cached Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8